Del Webb's Karyn and Jerry Waxman are hosting the PKD Applied Underwriters Invitational on Oct. 27 at Lakewood National Golf ...

Most cases of chronic kidney disease relate to underlying conditions, so the best treatment for you depends on your health ...

The global Renal Cyst Treatment Market is on a trajectory of steady expansion, with its estimated value at USD 203.2 million ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.

The National Kidney Foundation’s Memphis Kidney Walk took over Sequoyah Hills Park to raise awareness for kidney disease.

Indeed, simple liver cysts are almost always asymptomatic and found incidentally during routine testing for something else. These masses are not cancerous and not even dangerous. Simple cysts of the ...

A family is calling for urgent action after a father with a kidney disease died after developing sepsis. Reading resident Gareth Prodger, who lived with autosomal dominant polycystic kidney disease ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug. The drug, called povetacicept, is used for the treatment of IgA nephropathy, a type of kidney disease.

MONMOUTH, N.J., Sept. 18, 2025 /PRNewswire/ -- J & D Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company's ...

A research effort led by scientists from the Keck School of Medicine at the University of Southern California (USC) has led to the development of more mature and complex lab-grown kidney progenitor ...